Lexeo Therapeutics LXEO
NASDAQ LXEO
$3.07 +0.01 (+0.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Lexeo Therapeutics (LXEO) EBT Margin (2022)

Updated

Lexeo Therapeutics (LXEO) reported EBT Margin of -9063.76% for FY2022.

Analysis

Lexeo Therapeutics (LXEO) EBT Margin (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.13%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 27.75%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 26.27%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 45.21%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.90%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 20.41%
10 Lexeo Therapeutics 240.59 Mn -419.82 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 -3,211.86%
API Access

Lexeo Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=LXEO&period=max&api_key=YOUR_API_KEY